Published in J Xray Sci Technol on January 01, 2003
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol (2005) 5.55
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol (2010) 4.34
Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene (2005) 2.50
Processes for quality improvements in radiation oncology clinical trials. Int J Radiat Oncol Biol Phys (2008) 2.25
Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res (2004) 2.02
External Volume Expansion in Irradiated Tissue: Effects on the Recipient Site. Plast Reconstr Surg (2016) 2.02
Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol (2004) 1.82
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys (2010) 1.73
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study. J Clin Oncol (2012) 1.72
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood (2002) 1.70
Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. J Clin Oncol (2012) 1.67
Improving cancer outcomes through international collaboration in academic cancer treatment trials. J Clin Oncol (2009) 1.43
Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol (2004) 1.39
Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. Int J Radiat Oncol Biol Phys (2006) 1.32
Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin. J Biomed Opt (2012) 1.13
Hybrid IMRT plans--concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys (2005) 1.05
Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys (2005) 1.05
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. Med Pediatr Oncol (2002) 1.03
Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys (2009) 1.02
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group. Pediatr Blood Cancer (2012) 0.94
Hybrid IMRT for treatment of cancers of the lung and esophagus. Int J Radiat Oncol Biol Phys (2008) 0.94
Radiation therapy toxicity to the skin. Dermatol Clin (2008) 0.93
Future vision for the quality assurance of oncology clinical trials. Front Oncol (2013) 0.93
Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). Int J Radiat Oncol Biol Phys (2010) 0.89
Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery. Int J Radiat Oncol Biol Phys (2013) 0.89
Credentialing for participation in clinical trials. Front Oncol (2012) 0.89
Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer. Med Dosim (2004) 0.88
Skin perfusion and oxygenation changes in radiation fibrosis. Plast Reconstr Surg (2013) 0.85
A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma. Cancer (2010) 0.84
Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy. Med Phys (2006) 0.84
Chinese hamster ovary cell motility to fibronectin is modulated by the second extracellular loop of CD9. Identification of a putative fibronectin binding site. J Biol Chem (2002) 0.83
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1. J Cell Physiol (2013) 0.83
Volume Modulated Arc Therapy (VMAT) for pulmonary Stereotactic Body Radiotherapy (SBRT) in patients with lesions in close approximation to the chest wall. Front Oncol (2013) 0.83
PSA regulates androgen receptor expression in prostate cancer cells. Prostate (2011) 0.81
Dose distribution to spinal structures from intrathecally administered yttrium-90. Phys Med Biol (2005) 0.79
A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Gastrointest Cancer Res (2013) 0.78
Molecular targets for radiation oncology in prostate cancer. Front Oncol (2011) 0.78
Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation. Prostate (2008) 0.78
Assessment of Blood Flow in Solid Tumors Using PET. Clin Positron Imaging (1998) 0.77
Fractionated grid therapy in treating cervical cancers: conventional fractionation or hypofractionation? Int J Radiat Oncol Biol Phys (2007) 0.77
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. Int J Radiat Oncol Biol Phys (2009) 0.77
Development and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.76
Oncology scan - gynecological cancers: new treatments, old treatments, imaging, and meta-analyses. Int J Radiat Oncol Biol Phys (2013) 0.75
Reply: External Volume Expansion in Irradiated Tissue: Effects on the Recipient Site. Plast Reconstr Surg (2017) 0.75
Tumor imaging: radiation oncology perspective. Top Magn Reson Imaging (2006) 0.75
Increasing Fat Graft Retention in Irradiated Tissue After Preconditioning with External Volume Expansion." Plast Reconstr Surg (2019) 0.75